Image by The Library of Congress via Flickr
Transplanting stem cells from one’s own bone marrow (autologous stem cell transplants) improves the symptoms of muscular sclerosis (MS), and in some cases the neurological disease actually regressed. These are the encouraging results obtained from a small study performed on 21 remittent MS patients by a group from the Northwestern University School of Medicine in Chicago and published in Lancet Neurology. “All of the patients,” said the neurologists, “witnessed an improvement in their conditions three years after the stem cell transplants were performed. Of these, 81pct benefited from visible
The symptoms of multiple sclerosis could be reversed thanks to stem cell transplants from the patient’s own bone marrow, according to a study that will be published in March in Lancet Neurology by researchers from Northwestern University Feinberg School of Medicine in Chicago, who say that stem cell transplants could restore the immune system of patients suffering from the disease, stopping its evolution, and even causing its regression.
Multiple sclerosis is an autoimmune disease characterized by a defective immune system, which attacks the body’s own tissues in the central nervous system, and effects 57 thousand Italians. The disease
Researchers using stem cells must work to make their treatments safer after a 17 year-old boy with a rare genetic disease in 2001 was cured with an embryonic stem cell transplant in Moscow, but then developed benign brain and spinal tumors four years later. According to ‘Plos Medicine’ magazine, Israeli doctors removed cancer from the boy, the tumors developed due to a stem cell treatment that he received.
Image by markus the bardus via Flickr
A new experimental therapy to treat diabetes, which involves transplanting embryonic pig stem cells into the diseased tissue, is currently being researched. Experiments have been done on primates, but the results that have been obtained indicate that in the future the same technique could be applied to human beings. For many years, pig organs have been considered the most best match to be used in human transplants, but strong immune reactions and powerful combinations of anti-rejection drugs have always represented an important obstacle in their clinical use.
A study published in the
Gerhard Bauer, an American researcher and expert on ‘mother’ stem cells, during the 50th congress of the American Society of Hematology (ASH) in San Francisco, announced that human testing for an AIDS treatment based on genetically modified stem cells could begin within 5 years. Bauer has been working for the past 10 years on modified stem cells that could repair strongly compromised immune systems in HIV patients. “For this reason the apparent success obtained by German researchers on an American patient with AIDS and leukemia reinforces the idea that we are on the right path.”
Last month the German